3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
7
Gastrointestinal
5
Head & Neck
4
Genitourinary
4
Tumor-Agnostic
2
Thoracic
2
Sarcoma
2
Endocrine
2
Plasma cell
1
Other solid neoplasm
1
Lymphoid
1
Gynecologic
1
Breast
1
Conditions
Pituitary Neoplasms
2
Meningioma
2
Brain Neoplasms
2
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
lutetium Lu 177 dotatate
16
Magnetic Resonance Spectroscopy
14
gallium Ga 68 dotatate
9
Specimen Handling
8
Everolimus
8
pembrolizumab
7
cabozantinib
6
Cisplatin
6
fluorodopa F 18
5
Etoposide
5
trametinib
4
surufatinib
4
lanreotide
4
dabrafenib
4
cemiplimab
4
X-Rays
4
Temozolomide
4
Nivolumab
4
Lutetium-177
4
Lutetium
4
Fluorodeoxyglucose F18
4
Carboplatin
4
177Lu-octreotide, DOTA(0)-Tyr(3)-
4
olaparib
3
lenvatinib
3
copper dotatate CU-64
3
Transurethral Resection of Prostate
3
Thyrotropin Alfa
3
Surveys and Questionnaires
3
Somatostatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Proton Therapy
×
Endocrine
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT06831461
2025-09-16
PRIDE
Tata Memorial Centre
Phase NA
Recruiting
156 enrolled